Isomorphic Labs Delays First Clinical Trials to 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 20 2026
0mins
Source: Yahoo Finance
- Clinical Trial Delay: Isomorphic Labs' founder and CEO Demis Hassabis announced that the first clinical trials are now expected by the end of 2026, a delay from the previously anticipated end of 2025, indicating challenges in the drug development timeline.
- AI Drug Discovery Background: Founded in 2021 as a spin-off from Alphabet's AI research subsidiary Google DeepMind, the company focuses on leveraging artificial intelligence for drug discovery, highlighting its potential and prospects in innovative drug development.
- Industry Impact: The delay in clinical trials may affect investor confidence in Isomorphic Labs, particularly in the highly competitive biopharmaceutical sector, where timing setbacks could lead to a loss of market share.
- Future Outlook: Despite the delay, Hassabis remains optimistic about the potential of AI-designed drugs, indicating that the company will continue to push for advancements in the application of artificial intelligence in drug development, aiming for breakthrough progress in the future.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GOOG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GOOG
Wall Street analysts forecast GOOG stock price to fall
15 Analyst Rating
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 356.560
Low
255.00
Averages
336.08
High
400.00
Current: 356.560
Low
255.00
Averages
336.08
High
400.00
About GOOG
Alphabet Inc. is a holding company. The Company's segments include Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment includes infrastructure and platform services, collaboration tools, and other services for enterprise customers. Its Other Bets segment is engaged in the sale of healthcare-related services and Internet services. Its Google Cloud provides enterprise-ready cloud services, including Google Cloud Platform and Google Workspace. Google Cloud Platform provides access to solutions such as artificial intelligence (AI) offerings, including its AI infrastructure, Vertex AI platform, and Gemini for Google Cloud; cybersecurity, and data and analytics. Google Workspace includes cloud-based communication and collaboration tools for enterprises, such as Calendar, Gmail, Docs, Drive, and Meet.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Increased Financing Needs: Alphabet announced plans to raise $80 billion, with $10 billion coming from Berkshire Hathaway, indicating that despite strong profitability, the company requires additional funds to support future capital expenditures amid rising AI development demands.
- Capital Expenditure Expectations: Alphabet's projected capital expenditures for 2026 are around $170 billion, while operating cash flow over the past 12 months was $175 billion, suggesting that the company faces funding pressures as it expands its AI capabilities and needs to raise funds in advance to meet future spending.
- Equity Financing Strategy: By opting for equity rather than debt financing, Alphabet plans to sell approximately 2% of its shares, a strategy that helps minimize dilution while maintaining financial flexibility to address the escalating costs of AI development in a high stock price environment.
- Market Competition Dynamics: Alphabet's financing move contrasts with other companies like Anthropic, which raised $6.5 billion, highlighting the surging demand for computing power in the AI sector, and suggesting that Alphabet's actions may influence its competitive position in a rapidly evolving market.
See More
- Bull Market Review: Since President Trump's inauguration, the S&P 500 has surged 21%, demonstrating resilience despite pressures from U.S. import tariffs and turmoil in Iran, indicating sustained investor confidence in growth stocks.
- AI Stocks Leading Growth: Investors have flocked to AI-related stocks like Nvidia and Alphabet, driving their prices to double and triple-digit gains over the past year, reflecting high market recognition and expectations for the future potential of AI technologies.
- Increasing Market Uncertainty: While the S&P 500 is on track for a 6% increase in the first half, rising inflation and uncertainty surrounding Federal Reserve policies have tempered investor optimism, particularly when smaller companies fail to meet earnings expectations, leading to significant stock price volatility.
- Valuation Warning: The S&P 500 has reached historically high valuation levels, only previously seen during the dot-com bubble, suggesting potential adjustment risks in the market, prompting investors to exercise caution in response to possible future market fluctuations.
See More
- Significant Revenue Decline: C3.ai reported $250.3 million in revenue for fiscal 2026, reflecting a 35% year-over-year decline, indicating severe challenges in customer acquisition and retention that undermine its market competitiveness.
- Escalating Losses: The company incurred a net loss of $470.4 million in fiscal 2026, a 63% increase from the previous year's losses, forcing C3.ai to cut approximately 35% of its workforce to mitigate financial strain.
- Pessimistic Future Revenue Outlook: Management forecasts revenue between $210 million and $240 million for fiscal 2027, suggesting a year-over-year decline even at the upper end, highlighting significant hurdles in returning to growth.
- Stock Valuation Appears Cheap: While C3.ai's price-to-sales ratio stands at 6.1, below the five-year average of 10.5, the forward P/S ratio rises to 6.9 due to declining revenue expectations, indicating that investors should approach the stock with caution despite its falling price.
See More
- Management Disruption Impact: C3.ai's founder Thomas Siebel stepped down as CEO last year due to health issues, leading to a sharp decline in sales, highlighting the significant impact of management changes on business operations.
- Revenue Decline: C3.ai generated $250.3 million in revenue for fiscal 2026, a staggering 35% drop year-over-year, while the company reported a net loss of $470.4 million, which is 63% higher than the previous year's loss, indicating severe financial challenges.
- Layoffs and Restructuring: In response to declining revenues, C3.ai cut approximately 35% of its workforce, which may help reduce costs but could also limit the company's growth potential, with management forecasting revenues to further decline to between $210 million and $240 million in fiscal 2027.
- Valuation and Investment Risks: C3.ai's current price-to-sales ratio stands at 6.1, below its five-year average of 10.5, making it appear cheap; however, with future revenue expectations declining, its forward P/S ratio rises to 6.9, prompting investors to carefully assess its long-term investment value.
See More
- Cloud Market Status: Amazon's AWS dominates the global cloud infrastructure, contributing 59% of operating income in Q1 with a 28% year-over-year revenue growth, showcasing its strong performance in the AI trend.
- Microsoft vs. Google Cloud: Microsoft's Azure boasts a 40% growth rate, while Google Cloud leads with 63% growth, aided by its proprietary Tensor Processing Units (TPUs), which have helped Google catch up in AI infrastructure development.
- Emerging Cloud Companies: CoreWeave and Nebius, as neocloud companies, achieved year-over-year revenue growth of 112% and 684%, respectively, attracting major clients like Microsoft and Meta, indicating strong growth potential in AI computing demand.
- Future Growth Expectations: Analysts project CoreWeave's revenue growth rates of 147% and 97% for 2026 and 2027, while Nebius is expected to grow even faster at 551% and 224%, respectively; despite not being profitable yet, their rapid expansion potential has garnered significant market interest.
See More
- Cloud Market Growth: Amazon Web Services (AWS) accounted for 59% of Amazon's operating income in Q1, with a revenue growth rate of 28%, marking its fastest expansion in nearly four years, indicating strong potential for cloud computing as a profitable business.
- Microsoft and Google Performance: Microsoft Azure reported a growth rate of 40% in its latest quarter, while Google Cloud led with an impressive 63% growth, aided by its proprietary Tensor Processing Units (TPUs), allowing Google to rapidly catch up in AI infrastructure development.
- Emerging Companies' Rapid Expansion: CoreWeave and Nebius saw revenue growth of 112% and 684% year-over-year, respectively, with projections of 147% and 97% revenue growth for 2026 and 2027, highlighting significant market demand in the AI cloud computing sector.
- Investment Risks and Opportunities: Although CoreWeave and Nebius are still operating at a loss, their rapid growth and future profitability potential have garnered significant attention from Wall Street, prompting investors to weigh the risks against the potential for long-term returns.
See More










